Published in HealthLeaders on September 22, 2025 | Author: Spencer Allee, Chief AI Officer, Aspirion
Healthcare providers are experiencing a fundamental shift in denials management economics, driven by artificial intelligence innovations that are making previously unworkable claims financially viable. Spencer Allee, Chief AI Officer at Aspirion, reveals how advanced technology is reshaping revenue cycle management for hospitals nationwide.
Breaking Through Traditional Denials Management Barriers
Historically, approximately 60% of healthcare denials remained unaddressed due to prohibitive costs and resource requirements. Complex cases requiring extensive manual review—including medical records analysis, denial letter interpretation, and payer policy research—often consumed hours or days of expert time. This economic reality left significant revenue uncollected, particularly affecting low-dollar denials and DRG downgrades.
Large language models (LLMs) and AI-powered solutions are revolutionizing this landscape by processing unstructured healthcare data in minutes rather than hours. When combined with clinical expertise, these technologies enable providers to tackle previously abandoned denial categories, including partial denials and downgrades that were historically deemed unprofitable to pursue.
Measurable Performance Improvements in Revenue Recovery
AI implementation in denials management delivers quantifiable results across four critical metrics:
Lower Claim Thresholds: Advanced AI systems can economically process claims below traditional $10,000 minimums, expanding the universe of workable denials significantly.
Accelerated Time to Cash: Healthcare organizations report approximately 40-day improvements in payment cycles from account placement through resolution—a substantial benefit for hospital cash flow management.
Enhanced Success Rates: AI-assisted denials management consistently achieves 10-20 percentage point improvements in overturn rates compared to traditional methods.
Reduced Appeals Volume: Automated solutions decrease second and third appeal requirements by roughly 20%, streamlining the entire process.
Strategic Decision Framework for AI Adoption
Healthcare leaders evaluating AI denials management solutions should consider four key factors when choosing between building, buying, or partnering:
- Capacity: Organizations must assess their bandwidth and budget for multi-year AI development initiatives, including competition for specialized talent.
- Capabilities: Internal software development and scaling expertise determines feasibility of in-house solutions versus vendor partnerships.
- Culture: Leadership commitment to innovation, iteration, and learning from failures significantly impacts implementation success.
- Conviction: Timeline expectations influence strategy—internal development requires five-year commitments, while purchasing or partnering delivers faster ROI.
The Urgency of AI Implementation
Healthcare denial rates continue climbing as payers increasingly shift denials to the back end, knowing most health systems lack capacity for large-scale appeals management. This trend particularly affects partial denials and downgrades, creating mounting pressure on provider revenue cycles.
For healthcare organizations still managing denials without AI assistance, the technology gap may already represent a competitive disadvantage. The critical question isn’t whether to adopt AI-powered denials management, but rather how quickly organizations can develop and implement an effective AI strategy to protect revenue and improve financial performance.
Success in modern healthcare revenue cycle management increasingly depends on leveraging artificial intelligence to address the growing complexity and volume of payer denials while maintaining the clinical expertise necessary for successful appeals.
Read the full article here.